135 related articles for article (PubMed ID: 11766732)
1. The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment.
Lippert C; Seeger H; Wallwiener D; Mueck AO
Eur J Gynaecol Oncol; 2001; 22(5):331-5. PubMed ID: 11766732
[TBL] [Abstract][Full Text] [Related]
2. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
[TBL] [Abstract][Full Text] [Related]
3. Estradiol inhibits LDL oxidation: do the progestins medroxyprogesterone acetate and norethisterone acetate influence this effect?
Mueck AO; Seeger H; Lippert TH
Clin Exp Obstet Gynecol; 1998; 25(1-2):26-8. PubMed ID: 9841134
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
5. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of continuous combined and sequential combined medroxyprogesterone acetate-estradiol treatment on the proliferation of MCF-7 cells.
Lippert C; Seeger H; Wallwiener D; Mueck AO
Climacteric; 2000 Dec; 3(4):271-7. PubMed ID: 11910587
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha.
Perkins MS; Louw-du Toit R; Jackson H; Simons M; Africander D
Front Endocrinol (Lausanne); 2022; 13():959396. PubMed ID: 36187129
[TBL] [Abstract][Full Text] [Related]
8. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
[TBL] [Abstract][Full Text] [Related]
9. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
[TBL] [Abstract][Full Text] [Related]
10. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.
Ruan X; Neubauer H; Yang Y; Schneck H; Schultz S; Fehm T; Cahill MA; Seeger H; Mueck AO
Climacteric; 2012 Oct; 15(5):467-72. PubMed ID: 22335423
[TBL] [Abstract][Full Text] [Related]
11. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effect of progesterone, medroxyprogesterone acetate and norethisterone on the proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
J Br Menopause Soc; 2003 Mar; 9(1):36-8. PubMed ID: 12804312
[TBL] [Abstract][Full Text] [Related]
13. Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study.
Sweeney EE; Fan P; Jordan VC
Cancer Res; 2014 Dec; 74(23):7060-8. PubMed ID: 25304262
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).
Africander DJ; Storbeck KH; Hapgood JP
J Steroid Biochem Mol Biol; 2014 Sep; 143():404-15. PubMed ID: 24861265
[TBL] [Abstract][Full Text] [Related]
15. Tibolone versus 17beta-estradiol/norethisterone: effects on the proliferation of human breast cancer cells.
Lippert C; Seeger H; Wallwiener D; Mueck AO
Eur J Gynaecol Oncol; 2002; 23(2):127-30. PubMed ID: 12013108
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
Seeger H; Rakov V; Mueck AO
Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
[TBL] [Abstract][Full Text] [Related]
17. In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women.
Arteaga E; Rojas A; Villaseca P; Bianchi M; Arteaga A; Durán D
Menopause; 1998; 5(1):16-23. PubMed ID: 9689190
[TBL] [Abstract][Full Text] [Related]
18. Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.
Schneck H; Ruan X; Seeger H; Cahill MA; Fehm T; Mueck AO; Neubauer H
Gynecol Endocrinol; 2013 Feb; 29(2):160-3. PubMed ID: 23116217
[TBL] [Abstract][Full Text] [Related]
19. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.
Neubauer H; Ruan X; Schneck H; Seeger H; Cahill MA; Liang Y; Mafuvadze B; Hyder SM; Fehm T; Mueck AO
Menopause; 2013 May; 20(5):504-10. PubMed ID: 23615641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
